Cargando…
Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial Diseases
ROCK (Rho kinase) signaling regulates a wide spectrum of fundamental cellular events and is involved in a variety of pathological conditions. It has therefore attracted research interest as a potential therapeutic target for combating various diseases. We showed that inhibition of ROCK enhances cell...
Autores principales: | Okumura, Naoki, Kinoshita, Shigeru, Koizumi, Noriko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511675/ https://www.ncbi.nlm.nih.gov/pubmed/28751979 http://dx.doi.org/10.1155/2017/2646904 |
Ejemplares similares
-
Morphological Changes of Human Corneal Endothelial Cells after Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Administration: A Prospective Open-Label Clinical Study
por: Nakagawa, Hiroko, et al.
Publicado: (2015) -
Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction
por: Okumura, Naoki, et al.
Publicado: (2016) -
A selective inhibitor of the Rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma
por: Yamamoto, Mayumi, et al.
Publicado: (2012) -
Inhibition of TGF-β Signaling Enables Human Corneal Endothelial Cell Expansion In Vitro for Use in Regenerative Medicine
por: Okumura, Naoki, et al.
Publicado: (2013) -
A Close Look at the Clinical Efficacy of Rho-Associated Protein Kinase Inhibitor Eye Drops for Fuchs Endothelial Corneal Dystrophy
por: Kinoshita, Shigeru, et al.
Publicado: (2021)